Log in

Relevant bibliographies by topics / Memorial Sloan–Kettering Cancer Center risk

Contents

Journal articles
Books
Book chapters
Conference papers

Academic literature on the topic 'Memorial Sloan–Kettering Cancer Center risk'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Memorial Sloan–Kettering Cancer Center risk.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Memorial Sloan–Kettering Cancer Center risk"

1

Mizuno, Ryuichi, Akira Miyajima, Nozomi Hayakawa, et al. "Impact of precise quantitative assessment of visceral obesity on outcomes of patients with metastatic renal cell carcinoma treated with systemic therapy." Journal of Clinical Oncology 34, no. 2_suppl (2016): 597. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.597.

Full text

Abstract:

597 Background: With its excellent resolution of adipose tissue, CT presents precise quantitative assessment of visceral obesity. We assessed the impact of visceral obesity on progression free and overall survival in patients treated with systemic therapy for metastatic renal cell carcinoma. Methods: This retrospective cohort study included 114 patients treated with systemic therapy for metastatic renal cell carcinoma between 2007 and 2015 at Keio university hospital in Japan. The visceral fat area was measured at the level of umbilicus using CT. A visceral fat area ≥100cm2 was used as the def

APA, Harvard, Vancouver, ISO, and other styles

2

Kunte, Siddharth, Swathi Sangli, Alejandro Lemor, et al. "Early-onset pancreatic ductal adenocarcinoma (PDAC) at Memorial Sloan Kettering Cancer Center (MSKCC)." Journal of Clinical Oncology 35, no. 15_suppl (2017): e15736-e15736. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e15736.

Full text

Abstract:

e15736 Background: PDAC is a leading and rising cause of cancer-related mortality. There is infrequent description of patients and outcomes with PDAC diagnosed aged <=50 years old (Early onset PC: EOPC). We reviewed the epidemiology, risk factors, oncologic outcomes and genomic data of EOPC pts at MSKCC. Methods: Using an institutional dataline search, N=364 patients were identified with EOPC between 2008-2014 at MSKCC. N= 282 were included in final analysis based on data completeness. Results: Baseline characteristics are summarized in table 1. The average patient was male, aged between 40

APA, Harvard, Vancouver, ISO, and other styles

3

Noch, Evan K., Sameer F. Sait, Shama Farooq, Tanya M. Trippett, and Alexandra M. Miller. "A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center." Neuro-Oncology Practice 8, no. 3 (2021): 325–36. http://dx.doi.org/10.1093/nop/npaa083.

Full text

Abstract:

Abstract Background Extraneural metastasis of glioma is a rare event, often occurring in patients with advanced disease. Genomic alterations associated with extraneural glioma metastasis remain incompletely understood. Methods Ten patients at Memorial Sloan Kettering Cancer Center diagnosed with extraneural metastases of glioblastoma (9 patients) and gliosarcoma (1 patient) from 2003 to 2018 were included in our analysis. Patient characteristics, clinical course, and genomic alterations were evaluated. Results Patient age at diagnosis ranged from 14 to 73, with 7 men and 3 women in this group.

APA, Harvard, Vancouver, ISO, and other styles

4

Yi, Min, Funda Meric-Bernstam, Henry M. Kuerer, et al. "Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision." Journal of Clinical Oncology 30, no. 6 (2012): 600–607. http://dx.doi.org/10.1200/jco.2011.36.4976.

Full text

Abstract:

Purpose Prediction of patients at highest risk for ipsilateral breast tumor recurrence (IBTR) after local excision of ductal carcinoma in situ (DCIS) remains a clinical concern. The aim of our study was to evaluate a published nomogram from Memorial Sloan-Kettering Cancer Center to predict for risk of IBTR in patients with DCIS from our institution. Patients and Methods We retrospectively identified 794 patients with a diagnosis of DCIS who had undergone local excision from 1990 through 2007 at the MD Anderson Cancer Center (MDACC). Clinicopathologic factors and the performance of the Memorial

APA, Harvard, Vancouver, ISO, and other styles

5

Zhi, Iris, Diana E. Lake, Fiona Ehrich, et al. "Older patients with early-stage triple-negative breast cancer: The Memorial Sloan Kettering Cancer Center experience." Journal of Clinical Oncology 41, no. 16_suppl (2023): 12063. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.12063.

Full text

Abstract:

12063 Background: Approximately 15% of cases of early-stage triple-negative breast cancer (TNBC) are diagnosed in individuals over the age of 70. Despite studies indicating that older patients derive similar benefits from polychemotherapy as younger patients, breast cancer specific mortality among older patients remains disproportionately high. Use of the comprehensive geriatric assessment (CGA) and individualized risk tools can help tailor treatment and minimize negative side effects while preserving quality of life. We performed a retrospective analysis of patients ≥ 70 years of age diagnose

APA, Harvard, Vancouver, ISO, and other styles

6

de Alcantara Filho, Paulo, Deborah Capko, John Mitchel Barry, Monica Morrow, Andrea Pusic, and Virgilio S. Sacchini. "Nipple-Sparing Mastectomy for Breast Cancer and Risk-Reducing Surgery: The Memorial Sloan-Kettering Cancer Center Experience." Annals of Surgical Oncology 18, no. 11 (2011): 3117–22. http://dx.doi.org/10.1245/s10434-011-1974-y.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Caudle, A. S. "Nipple-Sparing Mastectomy for Breast Cancer and Risk-Reducing Surgery: The Memorial Sloan-Kettering Cancer Center Experience." Breast Diseases: A Year Book Quarterly 23, no. 3 (2012): 259–60. http://dx.doi.org/10.1016/j.breastdis.2012.07.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Daly, Bobby, Jennie Huang, Jane Maiorano, et al. "A Treatment-at-Home Pilot: Barriers to Home Cancer Care." Oncology Issues 39, no. 2 (2024): 45–53. http://dx.doi.org/10.3928/25731777-20240422-08.

Full text

Abstract:

In Brief During the COVID-19 public health emergency, patients with cancer faced significant challenges presenting for their in-clinic visits. In-home administration of intramuscular and subcutaneous therapies provided an opportunity to deliver antineoplastic therapy while lowering infection risk. This quality improvement study of adult patients with neuroendocrine and breast cancers at Memorial Sloan Kettering Cancer Center was conducted from February 16, 2022, to October 14, 2022, and involved nurses delivering outpatient pharmacy-dispensed in-home intramuscular or subcutaneous treatments. T

APA, Harvard, Vancouver, ISO, and other styles

9

Kutner, Allison, Danielle Love, Alina Markova, et al. "Supporting Virtual Dermatology Consultation in the Setting of COVID-19." Journal of Digital Imaging 34, no. 2 (2021): 284–89. http://dx.doi.org/10.1007/s10278-021-00425-6.

Full text

Abstract:

Abstract While telemedicine has been utilized with more frequency over the past two decades, there remained significant barriers to its broad implementation. The COVID-19 global pandemic served as a stimulus for rapid expansion and implementation of telemedicine services across medical institutions worldwide in order to maximize patient care delivery, minimize exposure risk among healthcare providers and patients alike, and avoid overcrowding of patient care facilities. In this experience report, we highlight the teledermatology initiatives executed by the Dermatology Service at Memorial Sloan

APA, Harvard, Vancouver, ISO, and other styles

10

Bazarbashi, Shouki, Abdullah Alsharm, Faisal Azam, Hazem El Ashry, and Jamal Zekri. "The clinical significance of routine risk categorization in metastatic renal cell carcinoma and its impact on treatment decision-making: a systematic review." Future Oncology 16, no. 34 (2020): 2879–96. http://dx.doi.org/10.2217/fon-2020-0500.

Full text

Abstract:

Aim: To analyze responses to first-line metastatic renal cell carcinoma (mRCC) treatment stratified by risk criteria. Patients & methods: Clinical trials and observational studies of patients aged ≥18 years, published January 2005–May 2019, were identified via Ovid from MEDLINE, EMBASE, the Cochrane Central Trials Register and the Cochrane Database of Systematic Reviews. Data extracted included progression-free survival (PFS), overall survival (OS) and objective response rate (ORR). Results: 47/1269 articles met eligibility criteria. Most studies stratified patients by International Metast

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Memorial Sloan–Kettering Cancer Center risk"

1

Kovner, Abba. Slon Ḳeṭering: Poʾemah. Hotsaʾat ha-Ḳibuts ha-meʾuḥad, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kovner, Abba. Slon Ḳeṭering: Poʼemah. ha-Ḳibuts ha-meuʼḥad, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Straus, Joan Sutton. A legacy of caring: The Society of Memorial Sloan-Kettering Cancer Center. The Society, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

United States. President's Cancer Panel. Meeting. President's Cancer Panel Meeting: Transcript of proceedings, January 24, 2005, Memorial Sloan-Kettering Cancer Center, New York, New York. National Cancer Institute, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kovner, Abba. Sloan-Kettering: Poems. Schocken, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Feiffer, Halley. Funny Thing Happened on the Way to the Gynecologic Oncology Unit at Memorial Sloan Kettering Cancer Center of New York City: A Play. Abrams, Inc., 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Funny Thing Happened on the Way to the Gynecologic Oncology Unit at Memorial Sloan Kettering Cancer Center of New York City. Dramatists Play Service, Incorporated, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Doctored results: The suppression of laetrile at Sloan-Kettering Institute for Cancer Research. Equinox Press, Inc., 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Feiffer, Halley. Funny Thing Happened on the Way to the Gynecologic Oncology Unit at Memorial Sloan Kettering Cancer Center of New York City. Overlook Press, The, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Breitbart, William S., and Shannon R. Poppito. Meaning-Centered Group Psychotherapy for Patients with Advanced Cancer. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199837250.001.0001.

Full text

Abstract:

The importance of spiritual well-being and the role of "meaning" in moderating depression, hopelessness and desire for death in terminally-ill cancer and AIDS patients has been well-supported by research, and has led many palliative clinicians to focus on the development of non-pharmacologic interventions that can help their patients address these issues. Individual Meaning-Centered Group Psychotherapy (IMCP), an intervention developed and rigorously tested by the Department of Psychiatry & Behavioral Sciences at Memorial Sloan-Kettering Cancer Center, is a seven-week program based around

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Memorial Sloan–Kettering Cancer Center risk"

1

Barakat, Richard R., and David R. Spriggs. "Memorial Sloan-Kettering Cancer Center Experience with Intraperitoneal Chemotherapy of Ovarian Cancer." In Regional Chemotherapy. Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-219-7_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

O’Reilly, Eileen M., and David P. Kelsen. "Memorial Sloan-Kettering Cancer Center Experience with Intraperitoneal Chemotherapy for Gastric Cancer." In Regional Chemotherapy. Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-219-7_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Malkin, M. G. "Interstitial Brachytherapy of Malignant Gliomas: The Memorial Sloan-Kettering Cancer Center Experience." In Molecular Neuro-oncology and Its Impact on the Clinical Management of Brain Tumors. Springer Berlin Heidelberg, 1994. http://dx.doi.org/10.1007/978-3-642-85039-4_12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Goyal, Amit, and Hiram S. Cody. "Sentinel Lymph Node Biopsy Radiotracer Technique at Memorial Sloan-Kettering Cancer Center." In Breast Surgical Techniques and Interdisciplinary Management. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6076-4_40.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Beal, Kathryn, Gil'ad N. Cohen, Beryl McCormick, Virgilio Sacchini, and Michael Zelefsky. "Intraoperative Radiation Therapy During Breast-Conserving Surgery; the Memorial Sloan—Kettering Cancer Center Technique." In Accelerated Partial Breast Irradiation. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-88006-6_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Clifton Ling, C. "Rainstorm Over Kyoto: Technology Development and Interdisciplinary Collaboration at Memorial Sloan Kettering Cancer Center." In True Tales of Medical Physics. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-91724-1_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Urban, Jerome A. "Conservative Treatment of Potentially Curable Minimal, Occult, and Early Breast Cancer: Experience At Memorial Sloan-Kettering Cancer Center, New York." In Early Breast Cancer. Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70192-4_24.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Yahalom, Joachim, and Subhash Gulati. "Autologous bone marrow transplantation for refractory or relapsed Hodgkin’s disease: The Memorial Sloan-Kettering Cancer Center experience using high-dose chemotherapy with or without hyperfractionated accelerated total lymphoid irradiation." In Annals of Oncology. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-7305-4_11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

"of clinical trials at New York’s Memorial Sloan-Kettering Cancer Center." In Encyclopedia of AIDS. Routledge, 1998. http://dx.doi.org/10.4324/9780203305492-46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

"How we do it: the Memorial Sloan-Kettering Cancer Center approach Daniel G Coit." In Sentinel Lymph Node Biopsy. CRC Press, 2001. http://dx.doi.org/10.3109/9780203215296-17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Memorial Sloan–Kettering Cancer Center risk"

1

Imran, S., M. B. Feinstein, E. Khusainova, J. Sauter, and D. E. Stover. "Clinical, Radiographic and Histopathologic Findings with Outcomes of Checkpoint Inhibitor Immunotherapy Induced Pneumonitis at Memorial Sloan Kettering Cancer Center (MSKCC)." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4737.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Oliveira, Leandro Gonçalves, Ana Claudia Gonçalves Lima, Frank Lane Braga Rodrigues, et al. "Pathologic complete response and efficacy with neoadjuvant anthracycline followed by paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer: A real-world experience of Brazil." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1082.

Full text

Abstract:

Objective: Compared with other subtypes of breast cancer, a higher percentage of HER2-positive patients achieve a pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT). Most randomized studies of neoadjuvant therapy in HER2-positive breast cancer have employed anthracycline and taxane-based NACT regimens. In the aggregate, these studies suggest a pCR rate approaching 50% among patients with operable HER2-positive disease receiving anthracycline, taxane, and trastuzumab-based therapy (AC-TH). In the phase II TRYPHAENA study, the pCR rate reported for the docetaxel, carboplatin,

APA, Harvard, Vancouver, ISO, and other styles

3

Leonard, C., R. Lei, A. Antell, et al. "Abstract P1-11-02: A comparison of models (physician, the Van Nuys prognostic index, the Memorial-Sloan-Kettering Cancer Center DCIS nomogram)to predict ipsilateral breast events in patients with ductal carcinoma in situ (DCIS) of the breast after breast-conserving surgery failed to replicate results of the oncotype DCIS recurrence score." In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-p1-11-02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!